Learn how to move your Alzheimer’s or other CNS drug discovery programs at “the speed of need.” Register for our Roundtable: “Science, Innovation and Hope: How to advance drug discovery for neurodegenerative diseases.” October 20 | 12:00 EST / 18:00 CET
https://t.co/77ugtnYJKC
What a fantastic day! After 2 years, we finally had an in-person Ncardia team event. We enjoyed a boat trip around Leiden and had the time to share joy face-to-face with all team members.
Would you like to join Ncardia? Visit our careers page
https://t.co/5vLMpFyBwM
Ya falta poco! 😍
En nada tenemos aquí nuestro ciclo de conferencias en neurociencia NeuroCENL 🧠🧡
No hay mejor plan, así que nos vemos en Utrecht el día 25 de junio. Apuntaos aquí! 👇 https://t.co/MmYjjF04y9
Learn how our iPSC-manufacturing capabilities can benefit your pipeline and help you meet your deadlines. Mariana Argenziano describes her daily work and the customer-driven solutions she and the team implement to provide an excellent service.
👉https://t.co/dtLCooAROu
Incorporating human #iPSC technology into #cardiac#drugdiscovery facilitates decision-making steps & brings efficiency and confidence to the process
Explore our custom hiPSC-based solutions & contact our experts to discuss your needs
https://t.co/kN3ZjWVHK9
iPSC-based models are physiologically relevant and bring precise safety and efficacy predictions.
Check out our Ncyte Cardiomyocytes - ventricular-like cardiomyocytes, suitable for functional, metabolic and structural studies
Request a quote
👉https://t.co/SNR3uatJTL
Discover how human iPSC-based cardiac disease models facilitate the study of genetic disease-modifiers and their functional effects on #LQTS type 2
Info based on the research article of Lettine van der Brink et al.
Learn more
👉https://t.co/FVBInkGClx
#iPSC#arrhythmia
This week we are celebrating the International Day of Women and Girls in Science! 3 of our female scientists share their experiences to encourage young girls to pursuit a scientific career
Join our team!
https://t.co/LOPml3zNqR
#WomenInScience#WomenInSTEM#WomenScienceDay
Leveraging patient-specific background data in your #preclinical research with #iPSC technology, will enable you to advance your #cardiac#drugdiscovery project more efficiently.
Discover more advantages of using iPSC-based cardiac models
👉 https://t.co/kjMshtYsCO
Leveraging patient-specific background data in your #preclinical research with #iPSC technology, will enable you to advance your #cardiac#drugdiscovery project more efficiently.
Discover more advantages of using iPSC-based cardiac models
👉 https://t.co/kjMshtYsCO
https://t.co/kebXanZF0f sales team celebrating 2021 results. De rest of the company joining online. Thanks @MarilynTeder and @Noelia_MuMar you helped us a lot as well!
Proud to have this conversation with Georgios and transforme it into this article piece. There is always more to learn from the experts
#scicomm#WritingMotivation#humanbiology
Learn about the current benefits & future uses of human #iPSC#cardiomyocytes for #cardiacdisease modeling & #drugdiscovery in our latest “Expert Insights” article featuring Dr. Georgios Kosmidis, Senior Scientist at Ncardia.
Read here 👉https://t.co/TwQrdrDdmB
Now that a #Pighearttransplant has been done, you may wonder: is the pig heart like a human #heart? Crick and colleagues answered this in 1998 (https://t.co/jPVjbWzDxv). For a quick highlight of their findings 🧵👇 @MedCrisis@load_dependent@drbilalmunir @jonepstein1
Learn how disease models based on iPSCs can help you make better predictions in the early stages of drug discovery.
Read our latest publication in the @IbiJournal, Volume 4, Issue 4, pages 26-29
👉https://t.co/4FQ3M2Z9x8
#drugdiscovery#iPSC#diseasemodeling
Have a look at this Research Highlights
There are more than 11 drugs for #neurodegenerativediseases identified using iPSCs, that are being evaluated in clinical trials!
Our team is expanding! Are you committed to science and looking to make a decisive contribution in an innovative company?
Ncardia is looking for assistant / associate scientists
👁️Have a look at our vacancies
https://t.co/9weFfkW0S9
#joboffer#ipsc#innovation